Eli Lilly

• Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial - Jan 8 () - Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with ​its psoriatic arthritis treatment Taltz, improved arthritis symptoms and ‌drove weight loss better than Taltz alone.7% of patients who
• Prediction: The S&P 500 $1 Trillion Club Will Double Between 2026 and 2030 - Several companies could see massive gains by 2030 to join the vaunted club.